Genesystem Co., Ltd. (363250) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genesystem Co., Ltd. (363250:KRX), powered by AI.

Current Price
₩6,800
P/E Ratio
-5.2
Market Cap
47.9B
Sector
Healthcare
What is the Genesystem Co., Ltd. stock price forecast?

Genesystem Co., Ltd. is currently trading at ₩6,800. View real-time AI analysis on Alpha Lenz.

What is Genesystem Co., Ltd. insider trading activity?

View the latest insider trading data for Genesystem Co., Ltd. on Alpha Lenz.

What is Genesystem Co., Ltd.'s P/E ratio?

Genesystem Co., Ltd.'s P/E ratio is -5.2.

Genesystem Co., Ltd.

₩6.80K
KRX363250
Ask about Genesystem Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Genesystem Co., Ltd. trades at a P/E of -5.2 (undervalued) with modest ROE of -38.2%.

Ask for details

Company Overview

Genesystem Co., Ltd. is a biotechnology company specializing in the development and commercialization of innovative diagnostic solutions. The primary focus of the company is to provide advanced molecular diagnostic systems that assist in the rapid and accurate detection of various diseases. Notably, the company has expanded its expertise into areas like infectious diseases, genetic disorders, and cancer diagnostics, providing healthcare professionals with essential tools for early intervention and precise treatment strategies. Its contributions are pivotal in enhancing the capabilities of laboratories and hospitals by streamlining diagnostic workflows and improving patient outcomes. Headquartered in South Korea, Genesystem Co., Ltd. stands out in the biotechnology industry for its commitment to research and development, consistently pushing the boundaries of diagnostic technologies in the global healthcare market.

CEO서유진
SectorHealthcare
IndustryDiagnostics & Research
Employees54

Company Statistics

(FY 2024)

Profile

Market Cap₩47.89B
Revenue₩1.21B
Shares Out7.04M
Employees54

Margins

Gross-150.68%
EBITDA-703.41%
Operating-837.45%
Pre-Tax-801.44%
Net-788.96%

Valuation

P/E-5.22
P/B2.42
EV/Sales38.54
EV/EBITDA-5.61
P/FCF-6.05

Growth (CAGR)

Rev 3Yr-54.98%
Rev 5Yr1.25%
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-27.69%
ROE-38.16%
ROIC-27.73%

Financial Health

Cash & Cash Equivalents₩5.62B
Net Debt₩2.40B
Debt/Equity36.66%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Genesystem Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩6,800 | Alpha Lenz